|
C12ORF57 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.521600E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.742200E-02 |
| Normal-vs-Stage2 |
7.044000E-02 |
| Normal-vs-Stage3 |
7.818600E-01 |
| Normal-vs-Stage4 |
2.796000E-01 |
| Stage1-vs-Stage2 |
5.538000E-01 |
| Stage1-vs-Stage3 |
2.557700E-02 |
| Stage1-vs-Stage4 |
1.459670E-02 |
| Stage2-vs-Stage3 |
5.753600E-02 |
| Stage2-vs-Stage4 |
4.416000E-02 |
| Stage3-vs-Stage4 |
4.119000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.493500E-02 |
| Normal-vs-AfricanAmerican |
8.770200E-01 |
| Normal-vs-Asian |
5.126000E-01 |
| Caucasian-vs-AfricanAmerican |
8.696100E-03 |
| Caucasian-vs-Asian |
9.896100E-02 |
| AfricanAmerican-vs-Asian |
5.299800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.855900E-03 |
| Normal-vs-Female |
8.389000E-01 |
| Male-vs-Female |
8.617000E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.195800E-01 |
| Normal-vs-Extreme_Weight |
1.001020E-01 |
| Normal-vs-Obese |
2.839800E-01 |
| Normal-vs-Extreme_Obese |
3.146000E-02 |
| Normal_Weight-vs-Extreme_Weight |
2.024000E-01 |
| Normal_Weight-vs-Obese |
4.629600E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.194190E-01 |
| Extreme_Weight-vs-Obese |
6.378600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.798200E-01 |
| Obese-vs-Extreme_Obese |
2.487000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.607200E-01 |
| Normal-vs-Age(41-60Yrs) |
1.011750E-01 |
| Normal-vs-Age(61-80Yrs) |
8.059800E-02 |
| Normal-vs-Age(81-100Yrs) |
9.115700E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.157800E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.893700E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.732000E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.058800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.776400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.079000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.476300E-03 |
| Normal-VS-Type2 PRCC |
2.929000E-01 |
| Normal-VS-KIRP CIMP |
4.155000E-01 |
| Normal-VS-Unclassified PRCC |
1.452760E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.438950E-01 |
| Type1 PRCC-VS-KIRP CIMP |
8.383100E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
4.423800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.214200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
6.416400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
8.920100E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.317400E-01 |
| Normal-vs-N1 |
7.000200E-01 |
| Normal-vs-N2 |
1.202380E-03 |
| N0-vs-N1 |
5.213600E-01 |
| N0-vs-N2 |
1.544390E-03 |
| N1-vs-N2 |
2.799200E-04 |
|
|
